SalMar Q1 Operating Profit Falls 21% on Lower Salmon Prices
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
SalMar ASA reported its first-quarter 2026 financial results on 20 May 2026, with operating profit declining 21% year-on-year. The Norwegian aquaculture giant posted an operating profit of NOK 3.4 billion for the quarter, down from NOK 4.3 billion in Q1 2025. The company cited lower salmon prices and increased biological costs as primary drivers for the profit contraction. This release provides key data on the health of one of the world's leading salmon producers ahead of the industry's peak season.
The salmon farming sector is navigating a period of volatile returns after a multi-year boom. The last comparable quarterly profit decline of this magnitude for SalMar occurred in Q2 2023, when operating income fell 25% year-on-year. That episode was also driven by a sharp, albeit temporary, correction in spot salmon prices following an extended period of high margins.
The current macro backdrop features persistent inflationary pressures on key operational inputs, including feed, energy, and labor. Central banks, including Norges Bank, maintain a cautious stance on interest rates, keeping financing costs elevated for capital-intensive farming operations. This environment squeezes producers from both the revenue and cost sides, testing operational efficiency.
What changed to trigger the weaker Q1 2026 result is a combination of supply and demand factors. Salmon supply from Norway and other major producing regions has been strong, contributing to a softening of global spot prices from the peaks seen in 2025. Concurrently, consumer demand in key European markets has shown signs of normalization post-inflation, reducing the pricing power producers enjoyed during previous tight-supply cycles.
SalMar's Q1 2026 financials reveal the direct impact of weaker pricing. The company's operating profit (EBIT) was NOK 3.4 billion, a decline of NOK 900 million from the prior year. This resulted in an EBIT per kilogram of NOK 35.2, down significantly from NOK 46.8 in Q1 2025. Revenues for the quarter totaled NOK 11.2 billion.
The harvested volume in Norway was 58,200 tonnes (GWT), showing operational scale. The company's reported operational EBIT margin compressed to 30.4%, compared to 38.5% in the same quarter last year. This margin compression highlights the sensitivity of profits to even modest shifts in the per-kilogram price of salmon.
A comparison of key metrics illustrates the shift. Before the price decline, SalMar generated NOK 46.8 of operating profit per kilogram of salmon harvested. After the price adjustment, that figure fell to NOK 35.2 per kilogram, a 25% drop in unit profitability. The company's performance contrasts with the broader Oslo Stock Exchange's Aquaculture Index, which is down approximately 12% year-to-date, underperforming the main OBX Index.
The results confirm margin pressure is a sector-wide issue, not isolated to SalMar. Direct peers like Mowi ASA and Lerøy Seafood Group are likely to report similar margin compression in their upcoming Q1 reports, given their exposure to the same global salmon price benchmarks. Investors should expect single-digit percentage declines in the share prices of these firms on the news as valuations adjust to lower near-term earnings forecasts.
A counter-argument exists that current price weakness is seasonal and temporary, with stronger demand expected in the second half of 2026 leading to a price recovery. Historical patterns often show price strength ahead of European summer holidays. However, the magnitude of the current biological cost inflation presents a new, persistent headwind that may cap margin recovery even if prices rebound.
Positioning data from recent weeks shows institutional investors have been net sellers of aquaculture stocks, anticipating this earnings downturn. Flow analysis indicates capital rotating out of primary producers like SalMar [SALM.OL] and into related sectors perceived as more stable, such as seafood processing equipment suppliers and feed technology firms. Short interest in the sector has crept higher, though it remains below extreme levels.
The immediate catalyst is the earnings report from Mowi ASA, scheduled for 28 May 2026. As the world's largest salmon farmer, its results and guidance will set the tone for the entire sector. The NASDAQ Salmon Index futures curve for Q3 and Q4 2026 will be critical for forecasting second-half profitability.
Key levels to watch include the spot price of Norwegian salmon, with a sustained break above NOK 110 per kilogram needed to signal a firm recovery. For SalMar's stock, technical support sits near the NOK 520 level, a zone that held during the 2023 selloff. A breakdown below this could trigger further de-risking by momentum funds.
The next major industry data point is the Norwegian Directorate of Fisheries' biomass report in early July, which will indicate the health and size of the standing stock in the sea. Any significant revision to expected harvest volumes for H2 2026 will directly impact supply forecasts and price models used by commodity desks.
SalMar has a dividend policy linked to profits, typically paying out 50-70% of annual net income. A sustained period of lower operating profit, as indicated by the Q1 result, directly pressures the underlying earnings pool used for distributions. While the final 2026 dividend will be determined by full-year results, analysts are likely to revise their dividend-per-share forecasts downward following this report, potentially by 15-20%.
Biological costs refer to expenses directly tied to fish health and survival rates. Key components include sea lice treatments, vaccines, and increased feed consumption due to sub-optimal growth conditions. These costs have risen due to stricter environmental regulations limiting treatment options and the industry's ongoing battle with sealice resistance. Higher biological costs reduce the volume of harvestable fish and increase the cost per kilogram produced, a major headwind to sector margins.
Yes, according to company updates, the pioneering offshore farming initiative remains a core long-term growth project. The first full-scale unit is scheduled for deployment in 2027. This project aims to move farming to exposed offshore locations, which could significantly improve fish welfare and growth rates by providing superior water quality and current flow, potentially reducing biological costs over the long term. Capital expenditure for this project is factored into SalMar's multi-year investment plan.
SalMar's profit decline signals a cyclical downturn in salmon farming margins, with pricing pressure and stubborn costs squeezing near-term earnings.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.